REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Ourofino S.A. (Brazil)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Ourofino S.A. Profile Updated: November 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Portuguese Download a sample report

Ouro Fino, founded in 1987, is the third largest animal health company in Brazil in terms of revenue, according to the National Association of Industrial Products for Animal Health (Sindan). The company develops and manufactures medicines, vaccines and other veterinary products in a factory in the town of Cravinhos, State of Sao Paulo, and sells its products to more than 4,700 customers in 13 countries in the Americas, Europe and Africa.

Headquarters
Rodovia Anhanguera, Sp 330, Km 298, Bloco C, 2 Andar, Setor Ourofino S.A., Distrito Industrial
Cravinhos; Sao Paulo; Postal Code: 14140000

Contact Details: Purchase the Ourofino S.A. report to view the information.

Website: http://ri.ourofino.com/

Basic Information
Total Employees:
Purchase the Ourofino S.A. report to view the information.
Outstanding Shares:
Purchase the Ourofino S.A. report to view the information.
Registered Capital:
Purchase the Ourofino S.A. report to view the information.
Financial Auditors:
Purchase the Ourofino S.A. report to view the information.
Incorporation Date:
May 15, 2014
Key Executives
Purchase this report to view the information.
Chairman of the Board of Directors
Purchase this report to view the information.
Chairman of the Board of Directors
Purchase this report to view the information.
Vice Chairman Board of Directors
Purchase this report to view the information.
Member of Board of Directors
Purchase this report to view the information.
Member of Board of Directors
Ownership Details
Purchase this report to view the information.
28.76%
Purchase this report to view the information.
27.53%
Subsidiaries
Ouro Fino Agronegocio Ltda.
100%
Ouro Fino Colombia S.A.S.
100%
Regenera - Medicina Veterinaria Avancada Ltda.
100%
Company Performance
Financial values in the chart are available after Ourofino S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BRL. Absolute financial data is included in the purchased report.
Net sales revenue
2.34%▲
Total operating revenue
2.87%▲
Operating profit (EBIT)
128.71%▲
EBITDA
83.93%▲
Net Profit (Loss) for the Period
N/A
Total assets
3.09%▲
Total equity
8.88%▲
Operating Profit Margin (ROS)
8.93%▲
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-3.66%▼
Quick Ratio
0.72%▲
Cash Ratio
0.25%▲

Similar companies

Eurofarma Laboratorios S.A.
 
Bayer S.A.
Novartis Biociencias S.A.
 
Nortec Quimica S.A.
Massen Produtos Biologicos S.A.
 
Wegmed - Caminhos Medicinais Ltda.
Watertech Solucoes Ambientais Ltda.
 
Villas Boas Radiofarmacos Brasil S.A.
Vida Biotecnologia Ltda.
 
Vic Pharma Industria e Comercio Ltda.

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo